The world is not enough - the value of increasing registry data in idiopathic pulmonary fibrosis

被引：3
作者：
Moor, C. C. [1 ]
Kreuter, M. [2 ,3 ]
Luppi, F. [4 ]
Wuyts, W. A. [5 ]
机构：
[1] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands
[2] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis Pneumol & Resp C, Thoraxklin, Heidelberg, Germany
[3] German Ctr Lung Res, Heidelberg, Germany
[4] Univ Milano Bicocca, Resp Unit, S Gerardo Hosp, Monza, Italy
[5] Univ Hosp Leuven, Dept Resp Med, Leuven, Belgium
来源：
RESPIRATORY RESEARCH | 2020年 / 21卷 / 01期
关键词：
PIRFENIDONE; NINTEDANIB; DIAGNOSIS; CAPACITY; OUTCOMES; SAFETY;
D O I：
10.1186/s12931-020-01377-1
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
[31]   Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis [J].
Strykowski, Rachel ;
Adegunsoye, Ayodeji .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) :209-228
[32]   EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis [J].
Doubkova, Martina ;
Svancara, Jan ;
Svoboda, Michal ;
Sterclova, Martina ;
Bartos, Vladimir ;
Plackova, Martina ;
Lacina, Ladislav ;
Zurkova, Monika ;
Binkova, Ilona ;
Bittenglova, Radka ;
Lost'akova, Vladimira ;
Merta, Zdenek ;
Siskova, Lenka ;
Tyl, Richard ;
Lisa, Pavlina ;
Suldova, Hana ;
Petrik, Frantisek ;
Psikalova, Jana ;
Rihak, Vladimir ;
Snizek, Tomas ;
Reiterer, Pavel ;
Homolka, Jiri ;
Musilova, Pavlina ;
Lnenicka, Jaroslav ;
Paluch, Peter ;
Hrdina, Roman ;
Kralova, Renata ;
Hortvikova, Hana ;
Strenkova, Jana ;
Vasakova, Martina .
CLINICAL RESPIRATORY JOURNAL, 2018, 12 (04) :1526-1535
[33]   Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry [J].
Wuyts, Wim A. ;
Dahlqvist, Caroline ;
Slabbynck, Hans ;
Schlesser, Marc ;
Gusbin, Natacha ;
Compere, Christophe ;
Maddens, Sofie ;
Rizzo, Shemra ;
Kirchgaessler, Klaus-Uwe ;
Bartley, Karen ;
Bondue, Benjamin .
PULMONARY THERAPY, 2022, 8 (02) :181-194
[34]   Acute Exacerbation of Idiopathic Pulmonary Fibrosis [J].
Kishaba, Tomoo .
MEDICINA-LITHUANIA, 2019, 55 (03)
[35]   Idiopathic pulmonary fibrosis: pathogenesis and management [J].
Giacomo Sgalla ;
Bruno Iovene ;
Mariarosaria Calvello ;
Margherita Ori ;
Francesco Varone ;
Luca Richeldi .
Respiratory Research, 19
[36]   Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan [J].
Chang, Cheng-Yu ;
Wei, Yu-Feng ;
Chen, Chung-Yu ;
Lai, Yi-Chun ;
Hu, Po-Wei ;
Hung, Jui-Chi ;
Chu, Chi-Hsiang ;
Chuang, Hsin-Tzu ;
Chang, Shih-Chieh .
FRONTIERS IN MEDICINE, 2023, 10
[37]   Pamrevlumab for the treatment of idiopathic pulmonary fibrosis [J].
Sgalla, Giacomo ;
Franciosa, Claudia ;
Simonetti, Jacopo ;
Richeldi, Luca .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) :771-777
[38]   Nintedanib for the treatment of idiopathic pulmonary fibrosis [J].
Varone, Francesco ;
Sgalla, Giacomo ;
Iovene, Bruno ;
Bruni, Teresa ;
Richeldi, Luca .
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (02) :167-175
[39]   Therapeutic advances in idiopathic pulmonary fibrosis [J].
Fraser, Emily ;
Hoyles, Rachel K. .
CLINICAL MEDICINE, 2016, 16 (01) :42-51
[40]   Pirfenidone for the treatment of idiopathic pulmonary fibrosis [J].
Xaubet, Antoni ;
Serrano-Mollar, Anna ;
Ancochea, Julio .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) :275-281
12345